CARRIE FLEMING: Open Payments
NPI 1467420307 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 14 payments from 12 companies in 2025. Trend: 2023 $31 · 2024 $0 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| GENZYME CORPORATION | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Medline Industries LP | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
Products named: WAYRILZ, ICLUSIG, KEYTRUDA QLEX, Enhertu, Nubeqa, GIVLAARI, KEYTRUDA, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
